Trial Details

Not Recruiting
Basic Information
Clinical ID c2968
Identifier EUCTR2015-002109-12-GB
Trial Title An Extension Study of APD334-003 in Patients with Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Ulcerative colitis _ MedDRA version: 20.0_ Level: LLT_ Classification code 10045365_ Term: Ulcerative colitis_ System Organ Class: 100000004856_ ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Name: APD334 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Not yet available Other descriptive name: APD334 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2-
Participant Information
Sponsor Arena Pharmaceuticals, Inc.
City -
Country/Region United States;Spain;Ukraine;Lithuania;Austria;Russia;Israel;United Kingdom;France;Czech Republic;Hungary;Canada;Poland;Belgium;Romania;Australia;Bulgaria;Germany;Latvia;New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date 2019-10-28
Completion Date 2018-11-01